FW: STOCK MARKET ALERT: PDPR Announces Increased Revenues
OTC FIRST ALERT - New Public Company of the Month Symbol: PDPR Market: PK Sector: Infant-Pediatric Prosthetics BREAKING NEWS: LAKE HARMONY, PA -- (MARKET WIRE) -- Dec. 01, 2003 -- IOCircuit.com Announces Increased Revenue PDPR. Pediatric Prosthetics, Inc. has recently recruited one of the finest Pediatric Orthotists in the country. BREAKING NEWS: LAKE HARMONY, PA -- (MARKET WIRE) -- Nov. 26, 2003 -- TheNewsWire.com Reiterates PDPR with a Buy Rating and announces that Pediatric Prosthetics, Inc. is continuing its efforts to recruit new prosthetists. Jim Furey of Lehman Brothers says, You want to own small stocks versus large stocks when economic growth is accelerating, which is exactly the period we're in now. PDPR's a small NEW company that's developed a strong niche in the Infant-Pediatric Prosthetics segment, estimated at over $100 million annually. The national prosthetics market is estimated at nearly $2 billion annually and is extremely fragmented. PDPR's infant segment of this market, ages 0 to 14 comprise of 5% or $100 million of the total $2 billion national prosthetic market. PDPR developed its strong hold on this segment by focusing only on the infant-pediatric prosthetics segment. In its segment, PDPR hopes to repeat the success Hanger, Inc. Hanger, Inc currently trades on the NYSE under HGR, has a market cap of approx. $366 million and trades at around $18. INFANT-PEDIATRIC PROSTHETICS MARKET Children ages 0 to 14 comprise of 5%, or $100 million, of the total $2 billion national prosthetic market. The vast majority of this 5% pediatric prosthetic market derives from babies born with a limb loss. There are approximately 145,000 first time amputations each year. Of these 145,000 first time amputations, less than 1% or approximately 1,000 babies are born with a limb loss. PDPR's the only infant-pediatric prosthetics company focusing on these unique needs MARKET POTENTIAL Focusing on this infant-pediatric need allows PDPR to generate a consistent revenue stream from childhood to adulthood. This annuity effect should compound earnings year after year and enable PDPR to enjoy stable growth. The cost from infancy to adulthood is anticipated to be over $200,000 for a below elbow amputee. Adults will spend an additional $200,000 on their artificial arms. Revenue growth is directly correlated with the physical growth of the children. PDPR MANAGEMENT TEAM The management team of PDPR is nationally recognized as the leading prosthetists in the infant-pediatric prosthetics field. PDRP's management's been featured in, Orthotics Prosthetics Business News, written up in Life Magazine, and some of the fitted children have appeared on national TV shows, including Good Morning America, Maury Povich, Phil Donahue, and 20-20. FINAL CONSIDERATIONS The last time information was disseminated on PDPR it increased to $0.45. PDPR developed a strong niche in the nearly $2 billion a year industry by addressing the specialized $100 million infant-pediatric need. PDPR is the only company specializing in the national needs of the Infant-Pediatric Prosthetics segment. Focusing on its niche in the infant-pediatric segment, allows PDPR to generate a consistent revenue stream from childhood to adulthood. This annuity effect should compound earnings year after year and enable PDPR to enjoy stable growth. Receive First Notice on Companies like PDPR ([EMAIL PROTECTED]) The information herein is for information purposes only and should not be construed as an offer or solicitation of an offer to buy or to sell securities. This assembled information is based on information supplied by the company, press releases, SEC filings, or from other sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The data contained herein is subject to change without notice. Small-cap companies, micro-cap companies, penny stocks and/or thinly traded securities are inherently risky and volatile; therefore the risk of losing some or all should be calculated. Please always do your own due diligence and consult a financial advisor. OTCFirstAlert accepts no liability for any losses arising from an investor's reliance on or use of this report. Affiliates of OTCFirstAlert have been hired by a third party and are to one million trading shares for the construction and dissemination of this information. OTCFirstAlert and its affiliates, officers, directors, members and employees may hold, buy or sell common shares of profiled companies in the open market without notice. On technical analysis may from time to time cause the target price to fluctuate without notice. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information
FW: STOCK MARKET ALERT: PDPR Announces Increased Revenues
OTC FIRST ALERT - New Public Company of the Month Symbol: PDPR Market: PK Sector: Infant-Pediatric Prosthetics BREAKING NEWS: LAKE HARMONY, PA -- (MARKET WIRE) -- Dec. 01, 2003 -- IOCircuit.com Announces Increased Revenue PDPR. Pediatric Prosthetics, Inc. has recently recruited one of the finest Pediatric Orthotists in the country. BREAKING NEWS: LAKE HARMONY, PA -- (MARKET WIRE) -- Nov. 26, 2003 -- TheNewsWire.com Reiterates PDPR with a Buy Rating and announces that Pediatric Prosthetics, Inc. is continuing its efforts to recruit new prosthetists. Jim Furey of Lehman Brothers says, You want to own small stocks versus large stocks when economic growth is accelerating, which is exactly the period we're in now. PDPR's a small NEW company that's developed a strong niche in the Infant-Pediatric Prosthetics segment, estimated at over $100 million annually. The national prosthetics market is estimated at nearly $2 billion annually and is extremely fragmented. PDPR's infant segment of this market, ages 0 to 14 comprise of 5% or $100 million of the total $2 billion national prosthetic market. PDPR developed its strong hold on this segment by focusing only on the infant-pediatric prosthetics segment. In its segment, PDPR hopes to repeat the success Hanger, Inc. Hanger, Inc currently trades on the NYSE under HGR, has a market cap of approx. $366 million and trades at around $18. INFANT-PEDIATRIC PROSTHETICS MARKET Children ages 0 to 14 comprise of 5%, or $100 million, of the total $2 billion national prosthetic market. The vast majority of this 5% pediatric prosthetic market derives from babies born with a limb loss. There are approximately 145,000 first time amputations each year. Of these 145,000 first time amputations, less than 1% or approximately 1,000 babies are born with a limb loss. PDPR's the only infant-pediatric prosthetics company focusing on these unique needs MARKET POTENTIAL Focusing on this infant-pediatric need allows PDPR to generate a consistent revenue stream from childhood to adulthood. This annuity effect should compound earnings year after year and enable PDPR to enjoy stable growth. The cost from infancy to adulthood is anticipated to be over $200,000 for a below elbow amputee. Adults will spend an additional $200,000 on their artificial arms. Revenue growth is directly correlated with the physical growth of the children. PDPR MANAGEMENT TEAM The management team of PDPR is nationally recognized as the leading prosthetists in the infant-pediatric prosthetics field. PDRP's management's been featured in, Orthotics Prosthetics Business News, written up in Life Magazine, and some of the fitted children have appeared on national TV shows, including Good Morning America, Maury Povich, Phil Donahue, and 20-20. FINAL CONSIDERATIONS The last time information was disseminated on PDPR it increased to $0.45. PDPR developed a strong niche in the nearly $2 billion a year industry by addressing the specialized $100 million infant-pediatric need. PDPR is the only company specializing in the national needs of the Infant-Pediatric Prosthetics segment. Focusing on its niche in the infant-pediatric segment, allows PDPR to generate a consistent revenue stream from childhood to adulthood. This annuity effect should compound earnings year after year and enable PDPR to enjoy stable growth. Receive First Notice on Companies like PDPR ([EMAIL PROTECTED]) The information herein is for information purposes only and should not be construed as an offer or solicitation of an offer to buy or to sell securities. This assembled information is based on information supplied by the company, press releases, SEC filings, or from other sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The data contained herein is subject to change without notice. Small-cap companies, micro-cap companies, penny stocks and/or thinly traded securities are inherently risky and volatile; therefore the risk of losing some or all should be calculated. Please always do your own due diligence and consult a financial advisor. OTCFirstAlert accepts no liability for any losses arising from an investor's reliance on or use of this report. Affiliates of OTCFirstAlert have been hired by a third party and are to one million trading shares for the construction and dissemination of this information. OTCFirstAlert and its affiliates, officers, directors, members and employees may hold, buy or sell common shares of profiled companies in the open market without notice. On technical analysis may from time to time cause the target price to fluctuate without notice. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information